Clinical data from 521 consecutive NICU patients were collected during the first 24 h of admission and were used to compare the predictive power of both scoring systems. RESULTS: The observed mortality rate was 10.0% compared with predicted mortality rates of 7.2% and 4.8% according to LODS and APACHE II, respectively. Both scoring systems had excellent discrimination but LODS had superior calibration. CONCLUSION: The LODS scoring system was more stable than the APACHE II scoring system in the NICU setting.
Introduction
Several disease severity and organ dysfunction scoring systems have been developed to predict outcomes in the critical care setting. 1 -5 The Logistic Organ Dysfunction System (LODS) is an organ dysfunction scoring system, 5 whereas Acute Physiology and Chronic Health Evaluation II (APACHE II) is a prognostic scoring system. 2 Organ dysfunction scoring systems are useful because organ failure is one of the leading causes of death in patients in the intensive care unit (ICU). 4, 5 LODS differs from other organ dysfunction scores in that it permits the calculation of predicted mortality based on the organ dysfunction score on the day of ICU admission. 6 Studies comparing the disease severity of critically ill patients and organ dysfunction scoring systems have generally been limited to predictions of survival in the general, rather than the neurological ICU (NICU). 7 The LODS scoring system has not been validated in NICU patient populations.
The aim of this study was to validate the performance of the LODS scoring system in comparison with the APACHE II scoring system, for all patients admitted to the NICU, for those with vascular brain injury (VBI) or for those with traumatic brain injury (TBI). 8 The Glasgow Coma Scale (GCS) score was evaluated ≥ 6 h after any operation or intervention in order to avoid poor scores due to the effects of anaesthesia. 9 Only the first NICU admission was included in this analysis in cases where patients were admitted to the unit more than once during a hospitalization period. Survival was assessed at NICU discharge.
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The study was approved by the Institutional Review Boards/Clinical Trials Centre at Bucheon St Mary's Hospital (reference number HC10RIS10004). All patients or their next-of-kin provided written informed consent.
STATISTICAL ANALYSES
The LODS and APACHE II scores were calculated during the first 24 h after admission for all patients. The predicted NICU mortality rate and risk of death were calculated using known formulae and published logistic equations (available at: http://www.sfar.org/scores2/apache22.html and http://www.sfar.org/scores2/lods2. php). 10, 11 Data were presented as mean ± SD or median (25th -75th percentiles) according to their distribution pattern, and compared using the χ 2 -test, Student's t-test (two-tailed) or Wilcoxon's rank-sum test. The LODS and APACHE II models for predicting mortality were tested with binary logistic regression analyses. The ability and accuracy of the models to predict the mortality rate were determined by examining their discrimination and calibration.
Discrimination was assessed using the area under the receiver operating characteristic curve (AUROC), and 95% confidence intervals (95% CI) were computed. Classification matrices were performed at decision criteria of 10%, 50% and 90%. Calibration of the prognostic models -defined as the accuracy of the estimated mortality rate -was assessed using the Hosmer-Lemeshow goodness-of-fit test, standardized mortality rate and calibration curves. Calibration curves were constructed by plotting predicted versus observed mortality rates after stratifying patients by 10% increments of predicted mortality. Discrimination and calibration were validated among the VBI and TBI groups in the same above-mentioned patterns. All statistical analyses were performed using the SAS ® statistical package, version 9.1 (SAS Institute Inc., Cary, NC, USA) for Windows ® . A P-value < 0.05 was considered statistically significant. TK Kim, JR Yoon LODS versus APACHE II in the NICU compared with those who survived (P < 0.0001 for both comparisons).
Results
The LODS and APACHE II scoring systems were assessed in the total patient population (n = 521). The AUROC was > 0.8 for both LODS and APACHE II ( Table 2) . Hosmer-Lemeshow goodness-of-fit tests generated P-values > 0.05 for both LODS and APACHE II, indicating that the models were comparable, although LODS had a better fit than APACHE II ( Table 2 ). The observed mortality was 10.0%, compared with predicted mortalities of 7.2% and 4.8% according to the LODS and APACHE II scoring systems, respectively. This betweentest difference in standardized mortality rate was not statistically significant. Calibration curves for the LODS and APACHE II scores are shown in Fig. 1 . The LODS calibration curve ( Fig. 1A ) was closer to the line of prediction than the APACHE II calibration curve ( Fig. 1B) . Calibration was more stable in LODS than in APACHE II. The overall correct classification rates for the total study population were highest when the cut-off values for the decision criteria were set at 90% for LODS and 50% for APACHE II (91.17% and 92.13%, respectively; Table 3 ).
The two scoring systems were investigated in patients with VBI (n = 293; 270 survived, 23 died). The AUROCs of LODS and APACHE II were both > 0.8 ( Table 2) . Hosmer-Lemeshow goodness-of-fit tests generated Pvalues > 0.05 for both scoring systems ( TK Kim, JR Yoon LODS versus APACHE II in the NICU II. The LODS calibration curve (Fig. 1C ) was closer to the line of prediction than the APACHE II calibration curve (Fig. 1D ).
In patients with TBI (n = 100; 86 survived, 14 died) the AUROC was > 0.9 for both LODS and APACHE II ( Table 2 ). Both scoring systems generated Hosmer-Lemeshow goodness-of-fit test P-values > 0.05 (Table 2) , with LODS having a better fit than APACHE II. APACHE II showed the highest overall correct classification in the VBI group and LODS showed the highest overall correct classification in the TBI group (Table 3 ). The LODS calibration curve (Fig. 1E ) was closer to the line of prediction than the APACHE II calibration curve (Fig. 1F ).
Discussion
Patients admitted to the NICU are likely to have a high risk of death, despite intensive treatment. An ideal ICU scoring system would identify groups of patients who are critically ill and require intensive care, and predict mortality as a group prognosis. 12 Most scoring systems have been developed in general ICU patients 7 and have not been validated specifically for the NICU. The LODS scoring system was developed from data supplied by The European/North American Study of Severity Systems in 1996 for the evaluation of organ dysfunction on the first day of an ICU stay. 10 Severity of organ failure was defined using 12 variables for six organ systems. LODS scoring also includes a logistic regression equation for predicting mortality. This system is easy to use, and allows simple calculation and prediction of hospital mortality. Previous studies of the LODS scoring system have demonstrated good discrimination and excellent calibration. 4, 6, 13, 14 The APACHE II system has been widely applied in many ICUs since 1985. 11 Studies have confirmed the correlation of the APACHE II system with outcomes in ICU patients. 15, 16 The APACHE II scoring system includes 12 physiological variables, chronic health status and patient age on the day of admission to the ICU. There has been controversy regarding the use of the APACHE II score to predict outcome. 15 -18 Discrimination of both scoring systems 
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was good in the present study, as the AUROC exceeded 0.70 -0.80, which is the level considered to be satisfactory. 19, 20 The overlapping 95% CI of the AUROC scores indicated that APACHE II had a similar predictive ability to LODS. Good discrimination by the APACHE II scoring system has been found in several studies, although some have reported unsatisfactory calibration. 21 -24 Several reports have indicated poor calibration when using LODS, 6, 25 but others have determined LODS to have excellent calibration. 4 The good calibration of LODS in the present study is similar to the findings of other studies performed in general or mixed ICUs. 20 -22 As an organ dysfunction scoring system, LODS cannot be a substitute for a prognostic scoring system such as APACHE II. 4 It is important to keep in mind that LODS was developed for the assessment of organ failure and not as a general severity scoring system. In addition, LODS cannot sufficiently reflect unpredictable treatment error, events after the first day of admission or comorbid conditions. 25 LODS may become more accurate through the use of customization and serial assessment. 6 The higher calibration of LODS than APACHE II among patients with VBI in the present study may be due to the greater contribution of systemic illnesses that accompany the formation of aneurysm and development of subarachnoid haemorrhage. Myocardial and pulmonary pathological changes are well-known systemic manifestations following subarachnoid haemorrhage. The underlying diseases and conditions in subarachnoid haemorrhage are numerous, including hypertension and heavy smoking related to chronic coronary and pulmonary pathologies. 26, 27 In accordance with the present study, Cho and Wang 28 found that the APACHE II scoring system had lower statistical value in the determination of mortality for TBI. They noted that > 80% of mortality from head injuries was due to failure of the central nervous system. 28 The proportion of the LODS score taken up by the GCS is a maximum of 5/22 (22.7%), which is higher than in the APACHE II scoring system (12/71; 16.9%), and the reason why LODS calibration was greater than that for APACHE II in patients with TBI.
The present study has several limitations. The study was conducted at a single centre with a limited sample size: sample size is known to have a major influence on the measured calibration when using the Hosmer-Lemeshow goodness-of-fit test. 29 In addition, a high dependency unit is not always used in neurocritical care, even in the institute where the present study was undertaken, and the influence of this policy on triage decisions may have affected the results. 30, 31 In conclusion, the present study found excellent discrimination for both the LODS and APACHE II scoring systems in predicting mortality in the NICU. There was no difference in the correct prediction of outcome between the two systems. LODS demonstrated better calibration than APACHE II in the NICU. LODS is simpler and faster than APACHE II, and its wider use would improve resource allocation, triage decisions and assist in clinical decisionmaking. More robust and specific methods for disease severity scoring are required to improve discrimination and calibration, in order to achieve accurate predictions of the mortality rate from neurological and neurosurgical illnesses.
